medigraphic.com
ISSN 1029-3019 (Electronic)

2013, Number 02

<< Back Next >>

MediSan 2013; 17 (02)

Gestational category of the antiphospholipid syndrome

Nápoles MD

Language: Spanish
References: 34
Page: 333-343
PDF size: 155.91 Kb.


ABSTRACT

A literature survey on primary antiphospholipid syndrome was conducted in order to provide an updated information as reference tool to guide diagnostic and therapeutic actions, aimed at treating pregnant women with this autoimmune disease and at decreasing not only the incidence of the thromboembolic disease in pregnancy, but also the pregnancy loss, preeclampsia, uterine growth retardation, which will contribute to the reduction of maternal and perinatal morbidity and mortality.


REFERENCES

  1. Harris EN, Chan JK, Asherson RA. Thrombosis recurrend fetal loss and thrombocytopenia. Predice value of the anticardolipin antibody test. Arch Intern Med. 1986; 146:2153-6.

  2. Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RH, Machin SJ, Barquinero J, et al. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine. 1989; 68:366-74.

  3. Alarcon Segovia D, Pérez Vázquez ME, Villa AR, Drenkard C, Cabiedes J. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum. 1992; 21:275-86.

  4. Orizondo Ansola R, Martínez Delgado JF, Montalván Cabrera J, Tápanes Cruz T. Prevención de las pérdidas fetales con prednisona y aspirina en pacientes con síndrome antifosfolípido primario. MEDICENTRO. 1999; 3(1):22.

  5. Orizondo Ansola R. Las pérdidas fetales en el síndrome antifosfolípido: Nuevos mecanismos patogénicos y opciones terapéuticas. Rev Cubana Obstet Ginecol. 1999; 25(3):146-52.

  6. Ramos Baquerizo P. Síndrome de anticuerpos antifosfolipídicos y pérdida gestacional recurrente. Revisión bibliográfica. Rev Ecuat Ginecol Obstet. 2000; 7(3):335-9.

  7. Arguedas Quesada JA. El síndrome de anticuerpo antifosfolipídico. Actualización Médica Periódica. 2012; 132.

  8. Alijotas Reig J, Vilardell Tarres M. Is obstetric antiphospholipid syndrome a primary nonthrombotic, proinflammatory, complement-mediated disorder related to antiphospholipid antibodies? Obstet Gynecol Surv. 2010; 65:39-45.

  9. Lockwood CS. The immunobiology and obstetrics of a phospholipid anti bidis. Obstet Gynecol Surv. 1999; 49:432-41.

  10. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006; 4:295-306.

  11. Tebo AE, Jaskowski TD, Phansalkar AR, Litwin CM, Branch DW, Hill HR. Diagnostic performance of phospholipid-specific assays for the evaluation of antiphospholipid syndrome. Am J Clin Pathol. 2008; 129:870_5.

  12. James AH. Pregnancy-associated thrombosis. Hematol. 2009 [citado 25 May 2011]; 1. Disponible en: http://asheducationbook.hematologylibrary.org/content/2009/1 /277.full

  13. Nápoles Méndez D, Couto Núñez D. Enfermedad tromboembólica venosa en el embarazo y puerperio. Parte 1: Enfoque de riesgo y diagnóstico. MEDISAN. 2011 [citado 22 Dic 2011];15(10). Disponible en:http://bvs.sld.cu/revistas/san/vol_15_10_11 /san121011.htm

  14. Lugones Botell M, Ramírez Bermúdez M, Israel López J. Síndrome antifosfolipídico. Algunos aspectos de interés para nuestra especialidad. Rev Cubana Obstet Ginecol. 2006; 32:3.

  15. The American College of Obstetrician and Gynecologists. Antiphospholipid syndrome. Practice Bulletin. 2012; 120(6):1514-21.

  16. Berkun Y, Padeh S, Barash J, Uziel Y, Harel L, Mukamel M, et al. Antiphospholipid syndrome and recurrent thrombosis in children. Arthritis Rheum.2006; 55:850_5.

  17. Alving BM. Diagnosis and management of patients with the antiphospholipid syndrome. J Thromb Thrombolysis. 2001; 12(1):89-93.

  18. Galindo García C, Bernárdez Zapah F, Hernández Marin I, Ayala Aguiles R. Síndrome antifosfolipídico y reproducción humana. Rev Ginecol Obstet Mex. 2007; 75:277-85.

  19. American Collage of Obstetricians and Gynecologists. Antiphospholipis syndrome. Practice Bulletin No 68. Obstet Gynecol. 2005; 106(5pt1):1113-21.

  20. Yamada H, Atsumi T, Kobashi G, Ota C, Kato EH, Tsuruga N, et al. Antiphospholipid antibodies increasethe risk of pregnancy-induced hypertension and adverse pregnancy outcomes. J Reprod Immunol. 2009; 79:188-95.

  21. Ruiz Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet. 2010; 376:1498-1509.

  22. Coronado Mestre R, López González A, Ortega Figueroa LM, Lima Rabelo Y. Síndrome de anticuerpos antifosfolipídicos en Obstetricia: presentación de dos casos. Rev Cubana Obstet Ginecol. 2008 [citado 25 may 2011]; 34:1. Disponible en: http://scielo.sld.cu/pdf/gin/v34n1/gin05108.pdf

  23. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002; 346(10):752-63.

  24. Correa PA, Valderrama CO, Angel GR, Saez CJ, Villablanca OE. Síndrome antifosfolipídico y embarazo. Rev Chilena Obstet Ginecol. 2002; 67(3): 196-202.

  25. Lim W, Crowther MA, Eikelboom JW. Management of antiphospholipid antibody syndrome: a systematic review. JAMA. 2006; 295:1050-7.

  26. Branch DW, Andres R, Digre KB, Rote NS, Scott JR. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol. 1989; 73:541_5.

  27. Nápoles Méndez D, Couto Núñez D. Experiencia de 11 años en enfermedad tromboembólica venosa en el período grávido puerperal. Rev Cubana Obstet Ginecol. 2011 [citado 12 Dic 2012]; 37(3). Disponible en:http://bvs.sld.cu/revistas/gin/vol37_3_11/gin02311.htm

  28. Monagle P, Chalmers E, Chan A, DeVeber G, Kirkham F, Massicotte P, et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition) Chest. 2008; 133:887S-968S.

  29. Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008; 133:844S-86S.

  30. Greaves M, Cohen H, MacHin SJ, Mackie I. Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol. 2000; 109(4):704-15.

  31. Kenet G, Lutkhoff LK, Albisetti M, Bernard T, Bonduel M, Brandao L, et al. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies. Circulation.2010; 121:1838-47.

  32. Díaz Concepción A. El síndrome antifosfolípido. Rev Cubana Hematol Inmunol Hemoter. 1998; 14(2): 67-79.

  33. Díaz Trujillo E, Elías Sierra R, Bordelois Abdo MS, Choo Ubals T, Fernández Fernández L. Síndrome antifosfolípido: informe de un caso. Rev Inf Cient. 2000; 27(3):7-7.

  34. Díaz Concepción A, Caunedo Almagro P, Zamora González Y. Determinación del anticoagulante lúpico: experiencia de 4 años. Rev Cubana Hematol Inmunol Hemoter. 2005 [citado 12 Dic 2012]; 21(1). Disponible en:http://www.bvs.sld.cu/revistas/hih/vol21_1_05/hih02105.htm




2020     |     www.medigraphic.com